REDWOOD CITY, Calif. — Directors are selling Xenoport (biopharmaceuticals) too cheaply through an unfair process to Arbor Pharmaceuticals, for $7.03 a share or $467 million, shareholders say in San Mateo County Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026